113 related articles for article (PubMed ID: 30077464)
1. Association Between Renal Cell Carcinoma and Myelodysplastic Syndromes: Epigenetic Underpinning?
Shenoy N; Mudireddy M; Vallapureddy R; Leung N; Pagliaro L; Witzig T; Ou FS; Ordog T; Cheville J; Patnaik M; Thompson RH; Tefferi A; Begna K
Clin Genitourin Cancer; 2018 Dec; 16(6):e1117-e1122. PubMed ID: 30077464
[TBL] [Abstract][Full Text] [Related]
2. Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: a single-center retrospective study.
Antonelli A; Arrighi N; Corti S; Zanotelli T; Cozzoli A; Cosciani Cunico S; Simeone C
Urol Oncol; 2013 Oct; 31(7):1310-5. PubMed ID: 22281433
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of renal cell carcinoma and hematologic malignancies (predominantly lymphoid) in individuals and in families.
Dutcher JP; Wiernik PH; Varella L; Chintapatla R
Fam Cancer; 2016 Oct; 15(4):677-87. PubMed ID: 27334456
[TBL] [Abstract][Full Text] [Related]
4. Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005-2010: a population-based study from the national Swedish kidney cancer register.
Thorstenson A; Bergman M; Scherman-Plogell AH; Hosseinnia S; Ljungberg B; Adolfsson J; Lundstam S
Scand J Urol; 2014 Jun; 48(3):231-8. PubMed ID: 24666102
[TBL] [Abstract][Full Text] [Related]
5. Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d'Or (Burgundy, France).
Maynadié M; Girodon F; Manivet-Janoray I; Mounier M; Mugneret F; Bailly F; Favre B; Caillot D; Petrella T; Flesch M; Carli PM
Haematologica; 2011 Jan; 96(1):55-61. PubMed ID: 20971817
[TBL] [Abstract][Full Text] [Related]
6. Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomide.
Rollison DE; Shain KH; Lee JH; Hampras SS; Fulp W; Fisher K; Al Ali NH; Padron E; Lancet J; Xu Q; Olesnyckyj M; Kenvin L; Knight R; Dalton W; List A; Komrokji RS
Cancer Med; 2016 Jul; 5(7):1694-701. PubMed ID: 27098006
[TBL] [Abstract][Full Text] [Related]
7. HTERT promoter methylation and single nucleotide polymorphism (-245 T>C) affect renal cell carcinoma behavior in Serbian population.
Trifunovic J; Basta Jovanovic G; Nikolic N; Carkic J; Marjanovic A; Brankovic M; Radojevic Skodric S; Prvanovic M; Jovanovic A; Dzamic Z; Milasin J
J BUON; 2018; 23(6):1887-1892. PubMed ID: 30610818
[TBL] [Abstract][Full Text] [Related]
8. Histopathological characteristics of adult renal tumours: a preliminary report.
Latif F; Mubarak M; Kazi JI
J Pak Med Assoc; 2011 Mar; 61(3):224-8. PubMed ID: 21465932
[TBL] [Abstract][Full Text] [Related]
9. Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses.
Gillett MD; Cheville JC; Karnes RJ; Lohse CM; Kwon ED; Leibovich BC; Zincke H; Blute ML
J Urol; 2005 Jun; 173(6):1893-6. PubMed ID: 15879770
[TBL] [Abstract][Full Text] [Related]
10. Family History and Risk of Renal Cell Carcinoma: A National Multiregister Case-Control Study.
Jakobsson RG; Nasic S; Bratt O; Johansson ME; Grenabo Bergdahl A
J Urol; 2024 Jan; 211(1):71-79. PubMed ID: 37862613
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.
Petraki CD; Gregorakis AK; Vaslamatzis MM; Papanastasiou PA; Yousef GM; Levesque MA; Diamandis EP
Tumour Biol; 2006; 27(1):1-7. PubMed ID: 16340244
[TBL] [Abstract][Full Text] [Related]
12. A comparison of overall survival and perioperative outcomes between partial and radical nephrectomy for cT1b and cT2 renal cell carcinoma-Analysis of a national cancer registry.
Venkatramani V; Koru-Sengul T; Miao F; Nahar B; Prakash NS; Swain S; Punnen S; Ritch C; Gonzalgo M; Parekh D
Urol Oncol; 2018 Mar; 36(3):90.e9-90.e14. PubMed ID: 29254672
[TBL] [Abstract][Full Text] [Related]
13. Renal cell carcinoma suspected at time of organ donation 2008-2016: A report of the OPTN ad hoc Disease Transmission Advisory Committee Registry.
Pavlakis M; Michaels MG; Tlusty S; Turgeon N; Vece G; Wolfe C; Wood RP; Nalesnik MA
Clin Transplant; 2019 Jul; 33(7):e13597. PubMed ID: 31104323
[TBL] [Abstract][Full Text] [Related]
14. The SWI/SNF chromatin-remodeling complex status in renal cell carcinomas with sarcomatoid or rhabdoid features.
Kinoshita F; Kohashi K; Sugimoto M; Takamatsu D; Kiyozawa D; Eto M; Oda Y
Virchows Arch; 2020 Nov; 477(5):651-660. PubMed ID: 32447490
[TBL] [Abstract][Full Text] [Related]
15. Genomic DNA Hypomethylation and Risk of Renal Cell Carcinoma: A Case-Control Study.
Mendoza-Pérez J; Gu J; Herrera LA; Tannir NM; Matin SF; Karam JA; Huang M; Chang DW; Wood CG; Wu X
Clin Cancer Res; 2016 Apr; 22(8):2074-82. PubMed ID: 26655847
[TBL] [Abstract][Full Text] [Related]
16. A Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona.
Ho TH; Nateras RN; Yan H; Park JG; Jensen S; Borges C; Lee JH; Champion MD; Tibes R; Bryce AH; Carballido EM; Todd MA; Joseph RW; Wong WW; Parker AS; Stanton ML; Castle EP
PLoS One; 2015; 10(7):e0132831. PubMed ID: 26181416
[TBL] [Abstract][Full Text] [Related]
17. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
[TBL] [Abstract][Full Text] [Related]
18. The establishment of KORCC (KOrean Renal Cell Carcinoma) database.
Byun SS; Hong SK; Lee S; Kook HR; Lee E; Kim HH; Kwak C; Ku JH; Jeong CW; Lee JY; Hong SH; Kim YJ; Hwang EC; Kwon TG; Kim TH; Kang SH; Kim SH; Chung J
Investig Clin Urol; 2016 Jan; 57(1):50-7. PubMed ID: 26966726
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic dysregulation of ID4 predicts disease progression and treatment outcome in myeloid malignancies.
Zhou JD; Zhang TJ; Li XX; Ma JC; Guo H; Wen XM; Zhang W; Yang L; Yan Y; Lin J; Qian J
J Cell Mol Med; 2017 Aug; 21(8):1468-1481. PubMed ID: 28452111
[TBL] [Abstract][Full Text] [Related]
20. Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy.
Moreira DM; Gershman B; Lohse CM; Boorjian SA; Cheville JC; Leibovich BC; Thompson RH
World J Urol; 2016 Oct; 34(10):1465-72. PubMed ID: 26914818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
